Details for: ALK

Gene ID: 238

Symbol: ALK

Ensembl ID: ENSG00000171094

Description: ALK receptor tyrosine kinase

Associated with

Other Information

Genular Protein ID: 3021441610

Symbol: ALK_HUMAN

Name: N/A

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 9174053

Title: ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK).

PubMed ID: 9174053

DOI: 10.1038/sj.onc.1201062

PubMed ID: 9053841

Title: Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system.

PubMed ID: 9053841

DOI: 10.1038/sj.onc.1200849

PubMed ID: 15815621

Title: Generation and annotation of the DNA sequences of human chromosomes 2 and 4.

PubMed ID: 15815621

DOI: 10.1038/nature03466

PubMed ID: 8122112

Title: Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.

PubMed ID: 8122112

DOI: 10.1126/science.8122112

PubMed ID: 17625570

Title: Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

PubMed ID: 17625570

DOI: 10.1038/nature05945

PubMed ID: 11387242

Title: The cytoplasmic truncated receptor tyrosine kinase ALK homodimer immortalizes and cooperates with ras in cellular transformation.

PubMed ID: 11387242

DOI: 10.1096/fj.00-0678fje

PubMed ID: 11121404

Title: Activation of anaplastic lymphoma kinase receptor tyrosine kinase induces neuronal differentiation through the mitogen-activated protein kinase pathway.

PubMed ID: 11121404

DOI: 10.1074/jbc.m007333200

PubMed ID: 11278720

Title: Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin.

PubMed ID: 11278720

DOI: 10.1074/jbc.m010660200

PubMed ID: 12112524

Title: Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor.

PubMed ID: 12112524

DOI: 10.1002/gcc.10033

PubMed ID: 11809760

Title: Pleiotrophin signaling through anaplastic lymphoma kinase is rate-limiting for glioblastoma growth.

PubMed ID: 11809760

DOI: 10.1074/jbc.m112354200

PubMed ID: 12107166

Title: Anti-apoptotic signaling of pleiotrophin through its receptor, anaplastic lymphoma kinase.

PubMed ID: 12107166

DOI: 10.1074/jbc.m203963200

PubMed ID: 12122009

Title: Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types.

PubMed ID: 12122009

DOI: 10.1074/jbc.m205749200

PubMed ID: 15226403

Title: ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth.

PubMed ID: 15226403

DOI: 10.1242/jcs.01183

PubMed ID: 15938644

Title: Unique substrate specificity of anaplastic lymphoma kinase (ALK): development of phosphoacceptor peptides for the assay of ALK activity.

PubMed ID: 15938644

DOI: 10.1021/bi0472954

PubMed ID: 15908427

Title: Differential induction of glioblastoma migration and growth by two forms of pleiotrophin.

PubMed ID: 15908427

DOI: 10.1074/jbc.m502614200

PubMed ID: 16317043

Title: Role of the subcellular localization of ALK tyrosine kinase domain in neuronal differentiation of PC12 cells.

PubMed ID: 16317043

DOI: 10.1242/jcs.02695

PubMed ID: 15592455

Title: Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.

PubMed ID: 15592455

DOI: 10.1038/nbt1046

PubMed ID: 16161041

Title: Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor.

PubMed ID: 16161041

DOI: 10.1002/ijc.21490

PubMed ID: 17274988

Title: ALK activation induces Shc and FRS2 recruitment: Signaling and phenotypic outcomes in PC12 cells differentiation.

PubMed ID: 17274988

DOI: 10.1016/j.febslet.2007.01.039

PubMed ID: 17681947

Title: Anaplastic lymphoma kinase is activated through the pleiotrophin/receptor protein-tyrosine phosphatase beta/zeta signaling pathway: an alternative mechanism of receptor tyrosine kinase activation.

PubMed ID: 17681947

DOI: 10.1074/jbc.m704505200

PubMed ID: 16878150

Title: Recruitment of insulin receptor substrate-1 and activation of NF-kappaB essential for midkine growth signaling through anaplastic lymphoma kinase.

PubMed ID: 16878150

DOI: 10.1038/sj.onc.1209840

PubMed ID: 19459784

Title: Anaplastic lymphoma kinase: signalling in development and disease.

PubMed ID: 19459784

DOI: 10.1042/bj20090387

PubMed ID: 22327622

Title: Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies.

PubMed ID: 22327622

DOI: 10.1038/nm.2673

PubMed ID: 25605972

Title: Heparin is an activating ligand of the orphan receptor tyrosine kinase ALK.

PubMed ID: 25605972

DOI: 10.1126/scisignal.2005916

PubMed ID: 30061385

Title: Identification of a biologically active fragment of ALK and LTK-Ligand 2 (augmentor-alpha).

PubMed ID: 30061385

DOI: 10.1073/pnas.1807881115

PubMed ID: 33411331

Title: ALK ligand ALKAL2 potentiates MYCN-driven neuroblastoma in the absence of ALK mutation.

PubMed ID: 33411331

DOI: 10.15252/embj.2020105784

PubMed ID: 20632993

Title: Crystal structure of the ALK (anaplastic lymphoma kinase) catalytic domain.

PubMed ID: 20632993

DOI: 10.1042/bj20100609

PubMed ID: 20695522

Title: Crystal structures of anaplastic lymphoma kinase in complex with ATP competitive inhibitors.

PubMed ID: 20695522

DOI: 10.1021/bi1005514

PubMed ID: 20454865

Title: Structural basis for the recognition of nucleophosmin-anaplastic lymphoma kinase oncoprotein by the phosphotyrosine binding domain of Suc1-associated neurotrophic factor-induced tyrosine-phosphorylated target-2.

PubMed ID: 20454865

DOI: 10.1007/s10969-010-9091-x

PubMed ID: 21575866

Title: CH5424802, a selective ALK inhibitor capable of blocking the resistant gatekeeper mutant.

PubMed ID: 21575866

DOI: 10.1016/j.ccr.2011.04.004

PubMed ID: 22932897

Title: The R1275Q neuroblastoma mutant and certain ATP-competitive inhibitors stabilize alternative activation loop conformations of anaplastic lymphoma kinase.

PubMed ID: 22932897

DOI: 10.1074/jbc.m112.391425

PubMed ID: 34646012

Title: Structural basis of cytokine-mediated activation of ALK family receptors.

PubMed ID: 34646012

DOI: 10.1038/s41586-021-03959-5

PubMed ID: 34819673

Title: Mechanism for the activation of the anaplastic lymphoma kinase receptor.

PubMed ID: 34819673

DOI: 10.1038/s41586-021-04140-8

PubMed ID: 17344846

Title: Patterns of somatic mutation in human cancer genomes.

PubMed ID: 17344846

DOI: 10.1038/nature05610

PubMed ID: 18724359

Title: Identification of ALK as a major familial neuroblastoma predisposition gene.

PubMed ID: 18724359

DOI: 10.1038/nature07261

PubMed ID: 18923523

Title: Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma.

PubMed ID: 18923523

DOI: 10.1038/nature07398

PubMed ID: 18923525

Title: Activating mutations in ALK provide a therapeutic target in neuroblastoma.

PubMed ID: 18923525

DOI: 10.1038/nature07397

PubMed ID: 21242967

Title: The constitutive activity of the ALK mutated at positions F1174 or R1275 impairs receptor trafficking.

PubMed ID: 21242967

DOI: 10.1038/onc.2010.595

Sequence Information:

  • Length: 1620
  • Mass: 176442
  • Checksum: 0733D6C4FD212F41
  • Sequence:
  • MGAIGLLWLL PLLLSTAAVG SGMGTGQRAG SPAAGPPLQP REPLSYSRLQ RKSLAVDFVV 
    PSLFRVYARD LLLPPSSSEL KAGRPEARGS LALDCAPLLR LLGPAPGVSW TAGSPAPAEA 
    RTLSRVLKGG SVRKLRRAKQ LVLELGEEAI LEGCVGPPGE AAVGLLQFNL SELFSWWIRQ 
    GEGRLRIRLM PEKKASEVGR EGRLSAAIRA SQPRLLFQIF GTGHSSLESP TNMPSPSPDY 
    FTWNLTWIMK DSFPFLSHRS RYGLECSFDF PCELEYSPPL HDLRNQSWSW RRIPSEEASQ 
    MDLLDGPGAE RSKEMPRGSF LLLNTSADSK HTILSPWMRS SSEHCTLAVS VHRHLQPSGR 
    YIAQLLPHNE AAREILLMPT PGKHGWTVLQ GRIGRPDNPF RVALEYISSG NRSLSAVDFF 
    ALKNCSEGTS PGSKMALQSS FTCWNGTVLQ LGQACDFHQD CAQGEDESQM CRKLPVGFYC 
    NFEDGFCGWT QGTLSPHTPQ WQVRTLKDAR FQDHQDHALL LSTTDVPASE SATVTSATFP 
    APIKSSPCEL RMSWLIRGVL RGNVSLVLVE NKTGKEQGRM VWHVAAYEGL SLWQWMVLPL 
    LDVSDRFWLQ MVAWWGQGSR AIVAFDNISI SLDCYLTISG EDKILQNTAP KSRNLFERNP 
    NKELKPGENS PRQTPIFDPT VHWLFTTCGA SGPHGPTQAQ CNNAYQNSNL SVEVGSEGPL 
    KGIQIWKVPA TDTYSISGYG AAGGKGGKNT MMRSHGVSVL GIFNLEKDDM LYILVGQQGE 
    DACPSTNQLI QKVCIGENNV IEEEIRVNRS VHEWAGGGGG GGGATYVFKM KDGVPVPLII 
    AAGGGGRAYG AKTDTFHPER LENNSSVLGL NGNSGAAGGG GGWNDNTSLL WAGKSLQEGA 
    TGGHSCPQAM KKWGWETRGG FGGGGGGCSS GGGGGGYIGG NAASNNDPEM DGEDGVSFIS 
    PLGILYTPAL KVMEGHGEVN IKHYLNCSHC EVDECHMDPE SHKVICFCDH GTVLAEDGVS 
    CIVSPTPEPH LPLSLILSVV TSALVAALVL AFSGIMIVYR RKHQELQAMQ MELQSPEYKL 
    SKLRTSTIMT DYNPNYCFAG KTSSISDLKE VPRKNITLIR GLGHGAFGEV YEGQVSGMPN 
    DPSPLQVAVK TLPEVCSEQD ELDFLMEALI ISKFNHQNIV RCIGVSLQSL PRFILLELMA 
    GGDLKSFLRE TRPRPSQPSS LAMLDLLHVA RDIACGCQYL EENHFIHRDI AARNCLLTCP 
    GPGRVAKIGD FGMARDIYRA SYYRKGGCAM LPVKWMPPEA FMEGIFTSKT DTWSFGVLLW 
    EIFSLGYMPY PSKSNQEVLE FVTSGGRMDP PKNCPGPVYR IMTQCWQHQP EDRPNFAIIL 
    ERIEYCTQDP DVINTALPIE YGPLVEEEEK VPVRPKDPEG VPPLLVSQQA KREEERSPAA 
    PPPLPTTSSG KAAKKPTAAE ISVRVPRGPA VEGGHVNMAF SQSNPPSELH KVHGSRNKPT 
    SLWNPTYGSW FTEKPTKKNN PIAKKEPHDR GNLGLEGSCT VPPNVATGRL PGASLLLEPS 
    SLTANMKEVP LFRLRHFPCG NVNYGYQQQG LPLEAATAPG AGHYEDTILK SKNSMNQPGP

Genular Protein ID: 2733380199

Symbol: B6D4Y2_HUMAN

Name: N/A

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 18923524

Title: Oncogenic mutations of ALK kinase in neuroblastoma.

PubMed ID: 18923524

DOI: 10.1038/nature07399

Sequence Information:

  • Length: 1620
  • Mass: 176454
  • Checksum: B31ED6C4FD27284F
  • Sequence:
  • MGAIGLLWLL PLLLSTAAVG SGMGTGQRAG SPAAGPPLQP REPLSYSRLQ RKSLAVDFVV 
    PSLFRVYARD LLLPPSSSEL KAGRPEARGS LALDCAPLLR LLGPAPGVSW TAGSPAPAEA 
    RTLSRVLKGG SVRKLRRAKQ LVLELGEEAI LEGCVGPPGE AAVGLLQFNL SELFSWWIRQ 
    GEGRLRIRLM PEKKASEVGR EGRLSAAIRA SQPRLLFQIF GTGHSSLESP TNMPSPSPDY 
    FTWNLTWIMK DSFPFLSHRS RYGLECSFDF PCELEYSPPL HDLRNQSWSW RRIPSEEASQ 
    MDLLDGPGAE RSKEMPRGSF LLLNTSADSK HTILSPWMRS SSEHCTLAVS VHRHLQPSGR 
    YIAQLLPHNE AAREILLMPT PGKHGWTVLQ GRIGRPDNPF RVALEYISSG NRSLSAVDFF 
    ALKNCSEGTS PGSKMALQSS FTCWNGTVLQ LGQACDFHQD CAQGEDESQM CRKLPVGFYC 
    NFEDGFCGWT QGTLSPHTPQ WQVRTLKDAR FQDHQDHALL LSTTDVPASE SATVTSATFP 
    APIKSSPCEL RMSWLIRGVL RGNVSLVLVE NKTGKEQGRM VWHVAAYEGL SLWQWMVLPL 
    LDVSDRFWLQ MVAWWGQGSR AIVAFDNISI SLDCYLTISG EDKILQNTAP KSRNLFERNP 
    NKELKPGENS PRQTPIFDPT VHWLFTTCGA SGPHGPTQAQ CNNAYQNSNL SVEVGSEGPL 
    KGIQIWKVPA TDTYSISGYG AAGGKGGKNT MMRSHGVSVL GIFNLEKDDM LYILVGQQGE 
    DACPSTNQLI QKVCIGENNV IEEEIRVNRS VHEWAGGGGG GGGATYVFKM KDGVPVPLII 
    AAGGGGRAYG AKTDTFHPER LENNSSVLGL NGNSGAAGGG GGWNDNTSLL WAGKSLQEGA 
    TGGHSCPQAM KKWGWETRGG FGGGGGGCSS GGGGGGYIGG NAASNNDPEM DGEDGVSFIS 
    PLGILYTPAL KVMEGHGEVN IKHYLNCSHC EVDECHMDPE SHKVICFCDH GTVLAEDGVS 
    CIVSPTPEPH LPLSLILSVV TSALVAALVL AFSGIMIVYR RKHQELQAMQ MELQSPEYKL 
    SKLRTSIIMT DYNPNYCFAG KTSSISDLKE VPRKNITLIR GLGHGAFGEV YEGQVSGMPN 
    DPSPLQVAVK TLPEVCSEQD ELDFLMEALI ISKFNHQNIV RCIGVSLQSL PRFILLELMA 
    GGDLKSFLRE TRPRPSQPSS LAMLDLLHVA RDIACGCQYL EENHFIHRDI AARNCLLTCP 
    GPGRVAKIGD FGMARDIYRA SYYRKGGCAM LPVKWMPPEA FMEGIFTSKT DTWSFGVLLW 
    EIFSLGYMPY PSKSNQEVLE FVTSGGRMDP PKNCPGPVYR IMTQCWQHQP EDRPNFAIIL 
    ERIEYCTQDP DVINTALPIE YGPLVEEEEK VPVRPKDPEG VPPLLVSQQA KREEERSPAA 
    PPPLPTTSSG KAAKKPTAAE ISVRVPRGPA VEGGHVNMAF SQSNPPSELH KVHGSRNKPT 
    SLWNPTYGSW FTEKPTKKNN PIAKKEPHDR GNLGLEGSCT VPPNVATGRL PGASLLLEPS 
    SLTANMKEVP LFRLRHFPCG NVNYGYQQQG LPLEAATAPG AGHYEDTILK SKNSMNQPGP

Database document:

This is a preview of the gene's schema. Only a few entries are kept for 'singleCellExpressions,' 'mRNAExpressions,' and other large data arrays for visualization purposes. You can zoom in with the mouse wheel for a closer view, and the text will adjust automatically if necessary. For the full schema, download it here.